Literature DB >> 9240529

Paramagnetic metal scavenging by melanin: MR imaging.

W S Enochs1, P Petherick, A Bogdanova, U Mohr, R Weissleder.   

Abstract

PURPOSE: To quantitate the binding of metals to synthetic melanin in vitro, which is believed to be the reason why melanotic melanomas are hyperintense on T1-weighted magnetic resonance (MR) images, and to test whether such binding by natural melanin can be detected in cultured melanoma cells in vivo with MR imaging.
MATERIALS AND METHODS: Seven synthetic metallomelanins were prepared and their metal contents and relaxivities determined. Melanotic PC1A and amelanotic B16 melanoma cells were incubated with increasing concentrations of iron. MR images of synthetic melanin and cell phantoms were obtained.
RESULTS: The iron-binding capacities and relaxivities of the different synthetic metallomelanins varied considerably, which reflects the heterogeneous structure of melanin and the complexity of its binding of metals. Nevertheless, the MR signal intensities of the synthetic melanin and cell phantoms show marked increases that scale, respectively, with increasing iron content and iron concentration in the incubation medium.
CONCLUSION: Melanotic melanomas are hyperintense on T1-weighted images because of paramagnetic metal scavenging. This observation has implications for the interpretation of MR images, the improved detection of melanomas, and the development of imaging marker genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240529     DOI: 10.1148/radiology.204.2.9240529

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  62 in total

1.  Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.

Authors:  Keita Kuya; Yuki Shinohara; Fuminori Miyoshi; Shinya Fujii; Yoshio Tanabe; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2016-01-16       Impact factor: 2.804

2.  Magnetic resonance imaging (MRI) appearances of primary amelanotic malign melanoma in the nasal cavity: a rare case.

Authors:  Hediye Pinar Gunbey; Emre Gunbey; Asli Tanrivermis Sayit; Kerim Aslan
Journal:  J Clin Diagn Res       Date:  2015-02-01

Review 3.  Gene expression and gene therapy imaging.

Authors:  Claire Rome; Franck Couillaud; Chrit T W Moonen
Journal:  Eur Radiol       Date:  2006-09-12       Impact factor: 5.315

4.  Quantitative magnetization transfer imaging of the human locus coeruleus.

Authors:  Paula Trujillo; Kalen J Petersen; Matthew J Cronin; Ya-Chen Lin; Hakmook Kang; Manus J Donahue; Seth A Smith; Daniel O Claassen
Journal:  Neuroimage       Date:  2019-06-21       Impact factor: 6.556

5.  Endometriosis of the superior gluteal nerve.

Authors:  S Reddy; D Porter; J T Patton; A Al-Nafussi; I Beggs
Journal:  Skeletal Radiol       Date:  2007-05-15       Impact factor: 2.199

Review 6.  In vivo tracking of cellular therapeutics using magnetic resonance imaging.

Authors:  Christoper M Long; Jeff W M Bulte
Journal:  Expert Opin Biol Ther       Date:  2009-03       Impact factor: 4.388

Review 7.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

8.  New insights into neurocutaneous melanosis.

Authors:  Ketsuda Jakchairoongruang; Yasmin Khakoo; Mark Beckwith; A James Barkovich
Journal:  Pediatr Radiol       Date:  2018-08-03

9.  Convertible manganese contrast for molecular and cellular MRI.

Authors:  Erik M Shapiro; Alan P Koretsky
Journal:  Magn Reson Med       Date:  2008-08       Impact factor: 4.668

10.  3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease.

Authors:  Kimihiro Ogisu; Kohsuke Kudo; Makoto Sasaki; Ken Sakushima; Ichiro Yabe; Hidenao Sasaki; Satoshi Terae; Mitsuhiro Nakanishi; Hiroki Shirato
Journal:  Neuroradiology       Date:  2013-03-23       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.